scispace - formally typeset
C

Chaker N. Adra

Researcher at Brigham and Women's Hospital

Publications -  59
Citations -  3685

Chaker N. Adra is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Gene & Atopy. The author has an hindex of 30, co-authored 59 publications receiving 3481 citations. Previous affiliations of Chaker N. Adra include Harvard University & Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

Immunomodulation by Mesenchymal Stem Cells A Potential Therapeutic Strategy for Type 1 Diabetes

TL;DR: Recent advances that have broadened the understanding of the immunomodulatory properties of MSC are focused on and insight is provided as to their potential for clinical use as a cell-based therapy for immune-mediated disorders and, in particular, type 1 diabetes.
Journal ArticleDOI

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

TL;DR: Bone marrow-derived murine MSC is characterized for their ability to modulate immune responses in the context of type 1 diabetes, as represented in NOD mice, to provide important preclinical data supporting the basis for further development of allogeneic MSC-based therapies for T1D and, potentially, for other autoimmune disorders.
Journal ArticleDOI

Atopy and asthma: genetic variants of IL-4 and IL-13 signalling

TL;DR: Genetic variants of IL-4/IL-13 signalling are discussed, and whether they promote asthma or atopy among different ethnic groups are discussed.
Journal ArticleDOI

A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.

TL;DR: A novel protein kinase A (PKA)–dependent signaling module, containing PKA and a putative A kinase adapter protein, Acyl CoA binding domain protein (ACBD)3, that interacts with TRPV2 in mast cells is described and it is proposed that regulated phosphorylation by PKA may be a common pathway forTRPV modulation.